420 related articles for article (PubMed ID: 21353376)
1. Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance.
Mason RJ; Abdolell M; Trottier G; Pringle C; Lawen JG; Bell DG; Jewett MA; Klotz L; Rendon RA
Eur Urol; 2011 May; 59(5):863-7. PubMed ID: 21353376
[TBL] [Abstract][Full Text] [Related]
2. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry.
Pierorazio PM; Johnson MH; Ball MW; Gorin MA; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME
Eur Urol; 2015 Sep; 68(3):408-15. PubMed ID: 25698065
[TBL] [Abstract][Full Text] [Related]
3. Active surveillance of renal masses: an analysis of growth kinetics and clinical outcomes stratified by radiological characteristics at diagnosis.
Dorin R; Jackson M; Cusano A; Haddock P; Kiziloz H; Meraney A; Shichman S
Int Braz J Urol; 2014; 40(5):627-36. PubMed ID: 25498286
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours.
Kim EH; Tanagho YS; Bhayani SB; Saad NE; Benway BM; Figenshau RS
BJU Int; 2013 May; 111(6):872-9. PubMed ID: 23145500
[TBL] [Abstract][Full Text] [Related]
5. Metastatic potential of a renal mass according to original tumour size at presentation.
Umbreit EC; Shimko MS; Childs MA; Lohse CM; Cheville JC; Leibovich BC; Blute ML; Thompson RH
BJU Int; 2012 Jan; 109(2):190-4; discussion 194. PubMed ID: 21557795
[TBL] [Abstract][Full Text] [Related]
6. Extended Duration of Active Surveillance of Small Renal Masses: A Prospective Cohort Study.
Whelan EA; Mason RJ; Himmelman JG; Matheson K; Rendon RA
J Urol; 2019 Jul; 202(1):57-61. PubMed ID: 30932757
[TBL] [Abstract][Full Text] [Related]
7. Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation.
Chen JX; Maass D; Guzzo TJ; Bruce Malkowicz S; Wein AJ; Soulen MC; Clark TWI; Nadolski GJ; William Stavropoulos S
J Vasc Interv Radiol; 2016 Sep; 27(9):1397-1406. PubMed ID: 27234485
[TBL] [Abstract][Full Text] [Related]
8. The natural history of incidentally detected small renal masses.
Volpe A; Panzarella T; Rendon RA; Haider MA; Kondylis FI; Jewett MA
Cancer; 2004 Feb; 100(4):738-45. PubMed ID: 14770429
[TBL] [Abstract][Full Text] [Related]
9. Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses.
Kunkle DA; Crispen PL; Li T; Uzzo RG
J Urol; 2007 May; 177(5):1692-6; discussion 1697. PubMed ID: 17437785
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
11. Explosive growth of a renal tumor during active surveillance.
Uhlman MA; Pate SC; Brown JA
Can J Urol; 2013 Apr; 20(2):6739-41. PubMed ID: 23587518
[TBL] [Abstract][Full Text] [Related]
12. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
13. Growth Kinetics of Small Renal Masses on Active Surveillance: Variability and Results from the DISSRM Registry.
Uzosike AC; Patel HD; Alam R; Schwen ZR; Gupta M; Gorin MA; Johnson MH; Gausepohl H; Riffon MF; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME; Pierorazio PM
J Urol; 2018 Mar; 199(3):641-648. PubMed ID: 28951284
[TBL] [Abstract][Full Text] [Related]
14. Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance.
Mehrazin R; Smaldone MC; Kutikov A; Li T; Tomaszewski JJ; Canter DJ; Viterbo R; Greenberg RE; Chen DY; Uzzo RG
J Urol; 2014 Sep; 192(3):659-64. PubMed ID: 24641909
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictors of benign lesions in renal masses smaller than 7 cm presumed to be renal cell carcinoma.
Akdogan B; Gudeloglu A; Inci K; Gunay LM; Koni A; Ozen H
Clin Genitourin Cancer; 2012 Jun; 10(2):121-5. PubMed ID: 22401753
[TBL] [Abstract][Full Text] [Related]
16. Can we avoid surgery in elderly patients with renal masses by using the Charlson comorbidity index?
O'Connor KM; Davis N; Lennon GM; Quinlan DM; Mulvin DW
BJU Int; 2009 Jun; 103(11):1492-5. PubMed ID: 19076135
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Delayed Intervention for Patients on Active Surveillance for Small Renal Masses: Does Renal Mass Biopsy Influence Our Decision?
Ambani SN; Morgan TM; Montgomery JS; Gadzinski AJ; Jacobs BL; Hawken S; Krishnan N; Caoili EM; Ellis JH; Kunju LP; Hafez KS; Miller DC; Palapattu GS; Weizer AZ; Wolf JS
Urology; 2016 Dec; 98():88-96. PubMed ID: 27450936
[TBL] [Abstract][Full Text] [Related]
18. Enhancing renal masses with zero net growth during active surveillance.
Kunkle DA; Crispen PL; Chen DY; Greenberg RE; Uzzo RG
J Urol; 2007 Mar; 177(3):849-53; discussion 853-4. PubMed ID: 17296355
[TBL] [Abstract][Full Text] [Related]
19. Active surveillance of small renal masses: progression patterns of early stage kidney cancer.
Jewett MA; Mattar K; Basiuk J; Morash CG; Pautler SE; Siemens DR; Tanguay S; Rendon RA; Gleave ME; Drachenberg DE; Chow R; Chung H; Chin JL; Fleshner NE; Evans AJ; Gallie BL; Haider MA; Kachura JR; Kurban G; Fernandes K; Finelli A
Eur Urol; 2011 Jul; 60(1):39-44. PubMed ID: 21477920
[TBL] [Abstract][Full Text] [Related]
20. Observation should be considered as an alternative in management of renal masses in older and comorbid patients.
Beisland C; Hjelle KM; Reisaeter LA; Bostad L
Eur Urol; 2009 Jun; 55(6):1419-27. PubMed ID: 19147267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
